Moreover, understanding bloating is crucial for comfort and managing it effectively
The extended pharmacokinetic profile allows therapeutic GLP-1 receptor activation throughout the day and night, providing continuous metabolic benefits rather than the transient effects of native GLP-1
Patients should diligently monitor and report side effects, understanding when to seek medical attention, especially if cramps become severe or persistent
In clinical trials, semaglutide (Wegovy) averaged about 14.9% of body weight over 68 weeks in the STEP 1 trial, and tirzepatide (Zepbound) averaged about 20.9% at the highest studied dose in SURMOUNT-1
Many patients find that the metabolic improvements, dietary habit changes, and weight reduction persist, supporting both natural conception and assisted reproduction outcomes
Willow earned the highest support grade in our review framework on this dimension